A 73-year-old woman was admitted to our hospital for a scheduled percutaneous transcatheter balloon valvuloplasty of a stenotic tricuspid bioprosthesis. The patient had a history consistent with exertional dyspnea, abdominal distension, and edema of the lower extremities resistant to diuretic treatment over the previous few months. Forty-three years prior, she underwent aortic valve replacement with a Starr-Edwards mechanical prosthetic valve, with a mean pressure gradient of 25 mm Hg, for aortic stenosis of rheumatic etiology ([Fig. 1](#F1){ref-type="fig"}, white arrow). Furthermore, three years after aortic valve replacement the patient underwent mitral valve replacement with a bileaflet mechanical valve for mitral stenosis which had a stenotic portion (mean pressure gradient 10 mm Hg) ([Fig. 1](#F1){ref-type="fig"}, black arrow), and tricuspid valve replacement with a Carpentier-Edwards bioprosthesis for tricuspid stenosis ([Fig. 1](#F1){ref-type="fig"}, yellow arrow). On admission, the patient was on atrial fibrillation and physical examination was compatible with right heart failure. Echocardiography demonstrated severe tricuspid stenosis and a mild regurgitation. The mean diastolic gradient across the tricuspid valve was 15.4 mm Hg ([Fig. 2A and B](#F2){ref-type="fig"}). Therefore, we proceeded to percutaneous valvuloplasty of the tricuspid valve using fluoroscopy, under regional anesthesia and sedation, inflating a 15×40-mm Inoue balloon up to a pressure of 15 atm ([Fig. 1B](#F1){ref-type="fig"}).[@B1][@B2] According to hemodynamic measurements, the gradient across the bioprosthetic tricuspid valve dropped from 13.0 mm Hg before to 6.0 mm Hg after dilation ([Fig. 3](#F3){ref-type="fig"}), and on repeat echocardiography the mean diastolic gradient was decreased to 7.2 mm Hg without worsening of the regurgitation ([Fig. 2C and D](#F2){ref-type="fig"}). The patient\'s symptoms soon improved; however, two months later she experienced a massive pulmonary hemorrhage while on heparin and acenocoumarol within therapeutic range, and died after a long hospitalization in the intensive care unit.
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